Bloodstream neutrophils do not express mRNA for interleukin-1beta (IL-
1beta), but transcripts for this cytokine are rapidly induced followin
g exposure to recombinant granulocyte-macrophage colony-stimulating fa
ctor (rGM-CSF) in vitro. Levels of IL-1beta mRNA reach maximal values
1 h after exposure to TGM-CSF and then decline to near basal levels by
4 h. Similarly, rGM-CSF treatment of blood neutrophils in vitro induc
ed increases in levels of mRNA for IL-6 and tumour necrosis factor-alp
ha (TNF-alpha). RNA extracted from neutrophils isolated from the synov
ial fluid of patients with rheumatoid arthritis expressed low, but sig
nificant levels of IL-1beta mRNA that were between 0.5 and 3% of the l
evels that could be maximally induced by rGM-CSF treatment of blood ne
utrophils. However, transcripts for TNF-alpha and IL-6 were not detect
ed in these synovial fluid neutrophils. mRNA for transforming growth f
actor-beta (TGF-beta) was constitutivety expressed in blood and synovi
al fluid neutrophils and transcripts for this cytokine were not altere
d by rGM-CSF exposure. Because of the transient nature of IL-1beta exp
ression by activated neutrophils, we propose that the low levels of ex
pression of mRNA for this cytokine in the synovial fluid neutrophils r
epresents expression by a small, perhaps newly-recruited and activated
, sub-population of cells. IL-1beta expression by this sub-population
may thus contribute to the pathogenesis of rheumatoid disease.